{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ABP+501", "query": { "intervention": "ABP 501" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 237, "total_pages": 24, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ABP+501&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-04T11:13:34.775Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03619876", "title": "Effects of Abatacept on Myocarditis in Rheumatoid Arthritis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Rheumatoid Arthritis", "Myocardial Inflammation" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2019-07-10", "completion_date": "2021-09-15", "has_results": true, "last_update_posted_date": "2023-05-08", "last_synced_at": "2026-09-04T11:13:34.775Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03619876" }, { "nct_id": "NCT02451748", "title": "IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Lab Work", "type": "OTHER" }, { "name": "Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of 200mg)", "type": "DRUG" }, { "name": "Certolizumab pegol (CDP870, tradename Cimzia)", "type": "DRUG" }, { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Sulfasalazine", "type": "DRUG" }, { "name": "Medrol", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Triamcinolone", "type": "DRUG" }, { "name": "Naproxen", "type": "DRUG" }, { "name": "Leflunomide", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "humira", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "University of Illinois at Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 32, "start_date": "2015-08", "completion_date": "2017-12", "has_results": true, "last_update_posted_date": "2024-07-10", "last_synced_at": "2026-09-04T11:13:34.775Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02451748" }, { "nct_id": "NCT02137226", "title": "BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "BI 695501", "type": "DRUG" }, { "name": "US-licensed Humira®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 645, "start_date": "2015-01-26", "completion_date": "2016-10-18", "has_results": true, "last_update_posted_date": "2018-01-19", "last_synced_at": "2026-09-04T11:13:34.775Z", "location_count": 63, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Glendale, Arizona + 51 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02137226" }, { "nct_id": "NCT04230213", "title": "A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "PF-06410293", "type": "DRUG" }, { "name": "adalimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 455, "start_date": "2020-01-13", "completion_date": "2021-06-22", "has_results": true, "last_update_posted_date": "2024-02-22", "last_synced_at": "2026-09-04T11:13:34.775Z", "location_count": 4, "location_summary": "Bowling Green, Kentucky • Duncansville, Pennsylvania • Dallas, Texas + 1 more", "locations": [ { "city": "Bowling Green", "state": "Kentucky" }, { "city": "Duncansville", "state": "Pennsylvania" }, { "city": "Dallas", "state": "Texas" }, { "city": "Beckley", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04230213" }, { "nct_id": "NCT01970475", "title": "Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "ABP 501", "type": "BIOLOGICAL" }, { "name": "Adalimumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 526, "start_date": "2013-10", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2016-12-13", "last_synced_at": "2026-09-04T11:13:34.775Z", "location_count": 5, "location_summary": "Victorville, California • Jupiter, Florida • Sandy Springs, Georgia + 2 more", "locations": [ { "city": "Victorville", "state": "California" }, { "city": "Jupiter", "state": "Florida" }, { "city": "Sandy Springs", "state": "Georgia" }, { "city": "Lansing", "state": "Michigan" }, { "city": "Middleburg Heights", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01970475" }, { "nct_id": "NCT03266471", "title": "Cytokines and Genes in Therapeutic Response in Crohn's Disease", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Inflammatory Bowel Diseases" ], "interventions": [ { "name": "Baseline blood sample", "type": "DIAGNOSTIC_TEST" }, { "name": "Baseline intestinal biopsies", "type": "DIAGNOSTIC_TEST" }, { "name": "Crohn's disease activity index (CDAI)", "type": "OTHER" }, { "name": "Post treatment blood sample", "type": "DIAGNOSTIC_TEST" }, { "name": "Post treatment intestinal biopsies", "type": "DIAGNOSTIC_TEST" }, { "name": "Baseline stool sample", "type": "DIAGNOSTIC_TEST" }, { "name": "Post treatment stool sample", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 96, "start_date": "2017-10-13", "completion_date": "2022-05-03", "has_results": false, "last_update_posted_date": "2023-04-14", "last_synced_at": "2026-09-04T11:13:34.775Z", "location_count": 2, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03266471" }, { "nct_id": "NCT04115748", "title": "Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Placebo to match filgotinib", "type": "DRUG" }, { "name": "Placebo to match adalimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 67, "start_date": "2019-12-03", "completion_date": "2021-05-11", "has_results": true, "last_update_posted_date": "2022-05-16", "last_synced_at": "2026-09-04T11:13:34.775Z", "location_count": 24, "location_summary": "Covina, California • Brandon, Florida • DeBary, Florida + 20 more", "locations": [ { "city": "Covina", "state": "California" }, { "city": "Brandon", "state": "Florida" }, { "city": "DeBary", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04115748" }, { "nct_id": "NCT05460390", "title": "Proactive Therapeutic Drug Monitoring Based Adalimumab Therapy Optimization in Patients With Rheumatoid Arthritis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Therapeutic drug monitoring (TDM)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Boston Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2022-10-26", "completion_date": "2024-06-30", "has_results": false, "last_update_posted_date": "2024-07-10", "last_synced_at": "2026-09-04T11:13:34.775Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05460390" }, { "nct_id": "NCT06941376", "title": "Pragmatic, Open-Label Study to Pilot Evaluation for Clinical Trials in Relapsing Polychondritis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Relapsing Polychondritis" ], "interventions": [ { "name": "Methotrexate (MTX)", "type": "DRUG" }, { "name": "Azathioprine (AZA)", "type": "DRUG" }, { "name": "Adalimumab", "type": "BIOLOGICAL" }, { "name": "Infliximab", "type": "BIOLOGICAL" }, { "name": "Tocilizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2025-11-11", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-09-04T11:13:34.775Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06941376" }, { "nct_id": "NCT00731757", "title": "Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcoidosis", "Cutaneous Sarcoidosis" ], "interventions": [ { "name": "Humira", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wright State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2009-05", "completion_date": "2010-12", "has_results": false, "last_update_posted_date": "2022-02-15", "last_synced_at": "2026-09-04T11:13:34.775Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00731757" } ] }